AI
IDXX icon

Atria Investments’s Idexx Laboratories IDXX Stock Holding History

Atria Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.64M Sell
10,043
-750
-7% -$481K 0.06% 337
2025
Q4 		$7.3M Buy
10,793
+1,659
+18% +$1.13M 0.08% 266
2025
Q3 		$5.84M Sell
9,134
-696
-7% -$422K 0.07% 336
2025
Q2 		$5.27M Buy
9,830
+7,780
+380% +$3.72M 0.06% 366
2025
Q1 		$861K Sell
2,050
-380
-16% -$165K 0.01% 1068
2024
Q4 		$1M Sell
2,430
-709
-23% -$311K 0.01% 982
2024
Q3 		$1.59M Sell
3,139
-946
-23% -$460K 0.02% 751
2024
Q2 		$1.99M Sell
4,085
-464
-10% -$233K 0.03% 645
2024
Q1 		$2.46M Buy
4,549
+470
+12% +$257K 0.03% 577
2023
Q4 		$2.26M Sell
4,079
-80
-2% -$37.6K 0.04% 551
2023
Q3 		$1.82M Sell
4,159
-100
-2% -$49.9K 0.03% 602
2023
Q2 		$2.14M Buy
4,259
+396
+10% +$190K 0.04% 527
2023
Q1 		$1.93M Sell
3,863
-379
-9% -$181K 0.04% 545
2022
Q4 		$1.73M Buy
4,242
+286
+7% +$111K 0.04% 562
2022
Q3 		$1.29M Buy
3,956
+397
+11% +$146K 0.03% 630
2022
Q2 		$1.25M Buy
3,559
+14
+0.4% +$5.71K 0.03% 665
2022
Q1 		$1.94M Buy
3,545
+679
+24% +$357K 0.03% 584
2021
Q4 		$1.89M Sell
2,866
-266
-8% -$167K 0.03% 586
2021
Q3 		$1.95M Sell
3,132
-1,436
-31% -$965K 0.04% 542
2021
Q2 		$2.88M Buy
4,568
+357
+8% +$197K 0.06% 384
2021
Q1 		$2.06M Sell
4,211
-7,725
-65% -$3.87M 0.05% 440
2020
Q4 		$5.97M Buy
11,936
+7,533
+171% +$3.37M 0.14% 166
2020
Q3 		$1.73M Buy
4,403
+790
+22% +$292K 0.05% 382
2020
Q2 		$1.19M Sell
3,613
-262
-7% -$75.9K 0.04% 456
2020
Q1 		$939K Buy
3,875
+1,543
+66% +$403K 0.07% 235
2019
Q4 		$609K Buy
2,332
+942
+68% +$248K 0.02% 712
2019
Q3 		$378K Sell
1,390
-335
-19% -$93.2K 0.01% 650
2019
Q2 		$477K Buy
+1,725
New +$425K 0.02% 595
2018
Q4 		– Sell
-1,405
Closed -$351K – 943
2018
Q3 		$351K Buy
+1,405
New +$341K 0.01% 713

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atria Investments's IDXX Position: Q1 2026 in Review

Atria Investments reduced its Idexx Laboratories (IDXX) stake by 6.9% in Q1 2026, selling an estimated $481K and leaving 10,043 shares worth $5.64M. The position accounts for 0.06% of the portfolio, ranked #337.

Atria Investments first reported a position in IDXX in Q3 2018 and has held it in 29 quarters since. The position peaked at $7.3M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Atria Investments held 10,043 shares of Idexx Laboratories worth $5.64M as of Q1 2026.
  • Atria Investments sold 750 Idexx Laboratories shares in Q1 2026, an estimated $481K.
  • Idexx Laboratories made up 0.06% of Atria Investments's portfolio in Q1 2026, its #337 holding.
  • Atria Investments first reported a position in Idexx Laboratories in Q3 2018 and has held it in 29 quarters since.
  • Atria Investments's Idexx Laboratories position peaked at $7.3M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.